Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Optum is a division of UnitedHealth Group ... FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback